Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

ACRVACRV
Showing 5 of 7 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in ACRIVON THERAPEUTICS INC

Yes. Two Sigma holds 641,498 shares of ACRV (Acrivon Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It increased the position by 252,103 shares (+64.7%) from Q1 2026. Two Sigma has held ACRV since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.1M

Current Shares

641,498

Total Value Change

+$926,271

Total Shares Change

+460,326

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
641,498
+64.7%
$1.1M0.0%$1.78
37
2026-Q1
Decreased
389,395
-33.4%
$541,2590.0%$1.39
0
2025-Q4
Increased
585,069
+83.3%
$1.4M0.0%$2.41
39
2025-Q3
Increased
319,205
+76.2%
$577,7610.0%$1.81
37
2025-Q2
New
181,172
-
$215,5950.0%$1.19
32

Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used